Study title:
Donaldson-S-S, Berberich-F-R, Kaplan-H-S.
Stanford Univ. Sch. Med., Stanford, Calif. 94305, United States.
A program of low dose radiation and MOPP chemotherapy for pediatric Hodgkin's disease.
Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-730).Donaldson-S-S, Berberich-F-R, Kaplan-H-S.
Stanford Univ. Sch. Med., Stanford, Calif. 94305, United States.
A program of low dose radiation and MOPP chemotherapy for pediatric Hodgkin's disease.
Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-730).
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|